Determinants of morbidity and mortality of systemic sclerosis in Canada

Seminars in Arthritis and Rheumatism
Firas F Al-DhaherJanine M Ouimet

Abstract

To describe the morbidity and mortality in Canadian scleroderma (SSc) patients focusing on gender, SSc type, and organ-specific prognosis in a cohort of patients seen from 1994 to 2004 in a Southwestern Ontario SSc clinic. We also compared this cohort to data from the literature, which showed that mean survival in recent studies has risen to 72 months versus 48 months in earlier studies. This was a cohort study of all SSc patients followed at 1 rheumatology center. Data were abstracted by chart review and entered into a database. The demographic and clinical characteristics of SSc patients were compared between those who survived versus those who died over the 10-year follow-up period. Five- and 10-year survival rates were compared between cohort subsets (sex, diffuse/limited disease type, and organ involvement including the following: scleroderma renal crisis, interstitial lung disease (ILD), hypertension, cardiac, gastrointestinal involvement, pulmonary arterial hypertension, and antinuclear antibody positivity). One hundred eighty-five subjects (158 women), 63% with limited cutaneous SSc, were included. The mean disease duration until last visit or death was 9.1 years (7.9 years in diffuse and 9.8 years in limited). Although...Continue Reading

References

Jul 1, 1976·The British Journal of Dermatology·N R Rowell
Apr 11, 1991·Arthritis and Rheumatism·R D AltmanB A Michel
Nov 1, 1971·Annals of the Rheumatic Diseases·R BennettE G Bywaters
May 1, 1971·Annals of Internal Medicine·T A Medsger, A T Masi
Dec 1, 1981·Australian and New Zealand Journal of Medicine·R J EasonP J Gow
Nov 5, 1997·Clinical Rheumatology·Z Nagy, L Czirják
Mar 13, 1998·Annals of the Rheumatic Diseases·C P SimeonG Sampol
Aug 26, 1998·British Journal of Rheumatology·S JacobsenS Ullman
Jan 30, 1999·Annals of the Rheumatic Diseases·R HesselstrandA Akesson
Sep 30, 1999·Environmental Health Perspectives·M D Mayes
Oct 18, 2000·Annals of Internal Medicine·V D Steen, T A Medsger
Nov 18, 2000·Arthritis and Rheumatism·V D Steen, T A Medsger
Jul 24, 2001·Arthritis and Rheumatism·O H GündüzT A Medsger
Dec 17, 2002·Arthritis and Rheumatism·Beverley J HarrisonAriane L Herrick
Jan 15, 2003·Annals of the Rheumatic Diseases·C MorganA J Silman
May 20, 2003·Internal Medicine Journal·J G WalkerP J Roberts-Thomson
Jul 5, 2003·Rheumatic Diseases Clinics of North America·Maureen D Mayes
Aug 9, 2003·Arthritis and Rheumatism·Maureen D MayesDavid Schottenfeld
Jan 11, 2005·The American Journal of Medicine·John P A IoannidisHaralampos M Moutsopoulos
Mar 3, 2007·Annals of the Rheumatic Diseases·Virginia D Steen, Thomas A Medsger

❮ Previous
Next ❯

Citations

Jan 17, 2013·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Anil S BhavsarArumugam Rajesh
Mar 17, 2011·PloS One·Christelle NguyenUNKNOWN Groupe Français de Recherche sur la Sclérodermie
Sep 8, 2011·Current Opinion in Rheumatology·Chintan S DesaiSanjiv J Shah
Oct 6, 2011·Nature Reviews. Rheumatology·Robyn T Domsic, Thomas A Medsger
Dec 4, 2009·Clinical Rheumatology·Jinhyun KimEun Bong Lee
Jan 10, 2009·Clinical Reviews in Allergy & Immunology·Vasiliki Kalliopi K BourniaM Eric Gershwin
Mar 27, 2012·Rheumatology·Janet E Pope
Oct 31, 2013·Expert Review of Clinical Immunology·Flavia V Castelino, John Varga
Nov 13, 2015·Expert Review of Clinical Immunology·Mike O Becker, Gabriela Riemekasten
Oct 25, 2014·Annals of the Rheumatic Diseases·Muriel ElhaiUNKNOWN EUSTAR co-authors
Jul 28, 2015·Arthritis Care & Research·Sara R SchoenfeldJ Antonio Aviña-Zubieta
Jan 20, 2016·The Journal of Dermatology·Koichi Yanaba
Jan 5, 2011·La Presse médicale·Paul M Hassoun
Oct 30, 2015·Medicine·C P Simeón-AznarUNKNOWN Spanish Society of Internal Medicine (SEMI)
Aug 27, 2010·Arthritis Care & Research·Sarit KhimdasUNKNOWN Canadian Scleroderma Research Group
Jun 16, 2010·Internal Medicine Journal·P HissariaP J Roberts-Thomson
May 29, 2010·Experimental Dermatology·Nicolas Hunzelmann, Thomas Krieg
Apr 12, 2016·Rheumatology International·Hadi PoormoghimNazanin Mojtabavi
Jun 17, 2014·Seminars in Arthritis and Rheumatism·Manuel Rubio-RivasVicent Fonollosa
May 26, 2015·Current Treatment Options in Rheumatology·Vivek NagarajaDinesh Khanna
May 18, 2016·International Journal of Cardiology·Sophie I MavrogeniJoao A C Lima
Aug 21, 2012·Annals of the Rheumatic Diseases·Ada ManHyon K Choi
Jun 15, 2016·International Journal of Environmental Research and Public Health·Jun KuraiEiji Shimizu
Sep 3, 2013·Lancet·Fiona Goldblatt, Sean G O'Neill
Oct 22, 2016·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Patrick KrummJoerg C Henes
May 31, 2014·BMJ Case Reports·Arwa AburizikChristopher Blosser
Sep 11, 2014·Current Opinion in Rheumatology·Donald F Kirby, Soumya Chatterjee
Jul 7, 2017·Nature Reviews. Rheumatology·Richard M Silver
Nov 9, 2017·Rheumatology International·Dilli Ram PoudelChris T Derk
Jun 7, 2018·Expert Review of Clinical Immunology·Maysoon Eldoma, Janet Pope
Nov 3, 2017·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·John B MillerZsuzsanna McMahan
Jul 19, 2011·The Journal of Rheumatology·Atsushi HashimotoShunsei Hirohata
Nov 3, 2012·The Journal of Rheumatology·Stylianos T PanopoulosPetros P Sfikakis
Oct 3, 2014·The Journal of Rheumatology·Haseena HusseinSindhu R Johnson
Jul 3, 2018·The Journal of Rheumatology·Grégory PugnetDominique Farge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.